Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Ryan

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Trees, forests, and other implications of a BRAF mutant gene signature in patients with BRAF wild-type diseaseJason E Faris, David P Ryan
The Lancet. Oncology|January 21, 2021
HIPEC for colorectal peritoneal metastasesSamuel J Klempner, David P Ryan
The Lancet. Oncology|August 1, 2012
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?Paul H Sugarbaker, David P Ryan
Cancer|December 1, 2007
Adjuvant therapy for pancreatic cancer: a reviewDan S Zuckerman, David P Ryan
JAMA Oncology|March 23, 2018
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer-The New Standard of Care?Theodore S Hong, David P Ryan
The Lancet. Oncology|June 15, 2014
The wide gulf between stage III and stage IV colon cancerDavid T Ting, David P Ryan
The Oncologist|February 10, 2015
Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?Ryan D Nipp, David P Ryan
Oncology (Williston Park, N.Y.)|May 9, 2003
Current perspectives on anal cancerJohanna C Bendell, David P Ryan
Annals of Surgery|May 14, 2020
Pancreatic Cancer: A Time to ChangeCristina R Ferrone, David P Ryan
Clinical Advances in Hematology & Oncology : H&O|June 20, 2020
The role of HIPEC in patients with advanced colorectal cancerDavid L Bartlett, David P Ryan
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Trees, forests, and other implications of a BRAF mutant gene signature in patients with BRAF wild-type diseaseJason E Faris, David P Ryan
The Lancet. Oncology|January 21, 2021
HIPEC for colorectal peritoneal metastasesSamuel J Klempner, David P Ryan
The Lancet. Oncology|August 1, 2012
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?Paul H Sugarbaker, David P Ryan
Cancer|December 1, 2007
Adjuvant therapy for pancreatic cancer: a reviewDan S Zuckerman, David P Ryan
JAMA Oncology|March 23, 2018
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer-The New Standard of Care?Theodore S Hong, David P Ryan
The Lancet. Oncology|June 15, 2014
The wide gulf between stage III and stage IV colon cancerDavid T Ting, David P Ryan
The Oncologist|February 10, 2015
Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?Ryan D Nipp, David P Ryan
Oncology (Williston Park, N.Y.)|May 9, 2003
Current perspectives on anal cancerJohanna C Bendell, David P Ryan
Annals of Surgery|May 14, 2020
Pancreatic Cancer: A Time to ChangeCristina R Ferrone, David P Ryan
Clinical Advances in Hematology & Oncology : H&O|June 20, 2020
The role of HIPEC in patients with advanced colorectal cancerDavid L Bartlett, David P Ryan
Pageof 28